European Patent Office Grants ONK Therapeutics'
The European Patent Office (EPO) has granted WEHI a patent for CISH knockout (KO) in Natural Killer (NK) cells which is exclusively licensed to ONK...
Source: globenewswire.com
Metabolic Reprograming News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Metabolic Reprograming. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Metabolic Reprograming Today - Breaking & Trending Today
ONK Therapeutics Secures Exclusive Global License to Patent for CISH Knockout in NK Cells for the Treatment of Cancer, from Australias WEHI
Posted on 539 ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has entered into an exclusive global patent license agreement with Australia’s Walter and Eliza Hall Institute of Medical Research (WEHI) providing rights to CISH KO in the field of NK cells for the treatment of cancer. “Deletion of CISH in NK cells leads to an improved metabolic profile, greatly enhances their proliferation, cytotoxicity, and persistence. In-vivo models of cancer have shown that CISH KO NK cells...
Source: financialbuzz.com
ONK Therapeutics Secures Exclusive Global License to Patent for CISH Knockout in NK Cells for the Treatment of Cancer, from Australia's WEHI
Cytokine Inducible SH2 containing protein (CIS; encoded by the gene CISH) is a potent checkpoint in NK cell-mediated tumor immunity CISH knockout (KO) NK cells have been shown to be more efficient
Source: finanznachrichten.de